Balance Sheet Selvita S.A.

Equities

SLV

PLSLVCR00029

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:55:53 2026-04-20 am EDT			5-day change	1st Jan Change
36.25 ^PLN	+2.11%		+11.54%	-16.09%

Apr. 02	Selvita receives EUR 1.3 mln order from European biopharmaceutical company	RE
Mar. 31	Selvita estimates Q1 consolidated operating revenue at 78-82 mln zlotys	RE

49a966873877b4eacd.EVlcAWOF_vCRg3zJbQTw2VGUi3tR_2kYWrp_60hdpMg.cygFVjbQx8DdsT-wJHPG7Rn88k4ApyhaMtY1uiMky5pCNQtnBe-dsanLKQ

Published financial data: SELVITA S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	137M	316M	416M	352M	346M
Other Revenues, Total	4.57M	-	-	-	-
Total Revenues	142M	316M	416M	352M	346M
Cost of Goods Sold, Total	21M	59.66M	68.39M	71.16M	74.19M
Gross Profit	121M	256M	347M	281M	272M
Selling General & Admin Expenses, Total	85.19M	197M	254M	206M	206M
Provision for Bad Debts	25.21K	520K	-	-	-
Depreciation & Amortization - (IS)	13.53M	27.49M	36.83M	45.45M	53.1M
Other Operating Expenses	2.66M	4.46M	11.38M	12.78M	13.37M
Other Operating Expenses, Total	101M	230M	303M	264M	272M
Operating Income	19.52M	26.33M	44.78M	16.75M	-488K
Interest Expense, Total	-628K	-3.8M	-4.2M	-11.68M	-12.27M
Interest And Investment Income	12.83K	13.93K	4K	512K	17K
Net Interest Expenses	-615K	-3.79M	-4.19M	-11.17M	-12.25M
Income (Loss) On Equity Invest.	-	-	-	-1.13M	-1.19M
Currency Exchange Gains (Loss)	-75.2K	-1.16M	-18K	10.34M	3.65M
Other Non Operating Income (Expenses)	-	-68.63K	-358K	52.42M	-175K
EBT, Excl. Unusual Items	18.83M	21.31M	40.21M	67.2M	-10.45M
Merger & Related Restructuring Charges	-	-688K	-	-	-
Gain (Loss) On Sale Of Assets	22.12K	40.44K	-	-	-
Other Unusual Items	-	403K	-	-	-
EBT, Incl. Unusual Items	18.85M	21.07M	40.21M	67.2M	-10.45M
Income Tax Expense	-1.07M	2.85M	7.6M	-2.68M	-4.36M
Earnings From Continuing Operations	19.92M	18.22M	32.61M	69.88M	-6.1M
Net Income to Company	19.92M	18.22M	32.61M	69.88M	-6.1M
Minority Interest	-1.92M	-3.32M	-2.3M	-	-
Net Income - (IS)	18M	14.9M	30.31M	69.88M	-6.1M
Net Income to Common Incl Extra Items	18M	14.9M	30.31M	69.88M	-6.1M
Net Income to Common Excl. Extra Items	18M	14.9M	30.31M	69.88M	-6.1M
Per Share Items
Net EPS - Basic	1.05	0.81	1.65	3.81	-0.33
Basic EPS - Continuing Operations	1.05	0.81	1.65	3.81	-0.33
Basic Weighted Average Shares Outstanding	17.21M	18.36M	18.36M	18.36M	18.36M
Net EPS - Diluted	1.05	0.81	1.65	3.81	-0.33
Diluted EPS - Continuing Operations	1.05	0.81	1.65	3.81	-0.33
Diluted Weighted Average Shares Outstanding	17.21M	18.36M	18.36M	18.36M	18.36M
Normalized Basic EPS	0.57	0.54	1.24	2.29	-0.36
Normalized Diluted EPS	0.57	0.54	1.24	2.29	-0.36
Supplemental Items
EBITDA	23.46M	38.42M	60.21M	37.86M	28.72M
EBITA	19.73M	29.59M	48.37M	20.21M	3.01M
EBIT	19.52M	26.33M	44.78M	16.75M	-488K
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	142M	316M	416M	352M	346M
Effective Tax Rate - (Ratio)	-5.66	13.51	18.9	-3.98	41.67
Total Current Taxes	1.22M	5.88M	6.37M	1.58M	1.68M
Total Deferred Taxes	-2.29M	-3.04M	1.22M	-4.26M	-6.04M
Normalized Net Income	9.85M	10M	22.83M	42M	-6.53M
Interest on Long-Term Debt	626K	1.31M	1.97M	3.56M	5.39M
Non-Cash Pension Expense	-	-82.17K	-291K	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	-	7.4M	49.08M	44.34M
Net Rental Expense, Total	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	30.84M	11.51M	3.19M
Total Stock-Based Compensation	-	-	30.84M	11.51M	3.19M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	93.01M	83.55M	74.16M	52.65M	22.51M
Short Term Investments	7.95M	6.23M	2.02M	311K	-
Total Cash And Short Term Investments	101M	89.78M	76.18M	52.96M	22.51M
Accounts Receivable, Total	25.51M	64.12M	84.16M	69.16M	79.16M
Other Receivables	10.95M	11.82M	29.85M	15.82M	9.77M
Notes Receivable	-	-	-	-	-
Total Receivables	36.46M	75.94M	114M	84.98M	88.93M
Inventory	2.23M	1.94M	7.8M	6.54M	6.86M
Prepaid Expenses	153K	765K	460K	520K	355K
Other Current Assets, Total	3.17M	10.7M	4.64M	6.24M	5.9M
Total Current Assets	143M	179M	203M	151M	125M
Gross Property Plant And Equipment	97.92M	210M	346M	423M	482M
Accumulated Depreciation	-35.68M	-60M	-87.91M	-115M	-161M
Net Property Plant And Equipment	62.23M	150M	258M	308M	320M
Long-term Investments	-	-	-	63.31M	62.12M
Goodwill	281K	76.73M	78.06M	72.06M	89.64M
Other Intangibles, Total	628K	37.18M	34.79M	29.56M	26.95M
Loans Receivable Long-Term	-	-	373K	-	-
Deferred Tax Assets Long-Term	12.34M	22.44M	10.09M	10.99M	16.75M
Other Long-Term Assets, Total	345K	829K	687K	1.31M	1.68M
Total Assets	219M	467M	585M	636M	642M
Liabilities
Accounts Payable, Total	10.43M	31.33M	36.76M	22.3M	32.26M
Accrued Expenses, Total	7.91M	22.48M	36.33M	16.66M	20.62M
Short-term Borrowings	4.64K	91.35K	138K	166K	4.42M
Current Portion of Long-Term Debt	-	11.13M	16.62M	19.52M	107M
Current Portion of Leases	12.77M	23.58M	24.7M	27.21M	31.15M
Current Income Taxes Payable	416K	2.76M	2.49M	75K	283K
Unearned Revenue Current, Total	1.32M	4.48M	5.47M	6.37M	7.18M
Other Current Liabilities	-	-	148K	1.46M	2.52M
Total Current Liabilities	32.85M	95.86M	123M	93.77M	206M
Long-Term Debt	-	80.97M	109M	113M	7.47M
Long-Term Leases	28.48M	64.03M	62.41M	64.97M	68.35M
Unearned Revenue Non Current	74.9K	2.04M	11.02M	33.01M	34.71M
Pension & Other Post Retirement Benefits	260K	530K	239K	988K	811K
Deferred Tax Liability Non Current	4.47M	17.61M	6.32M	3.57M	3.29M
Other Non Current Liabilities	-	-	-	1K	-1K
Total Liabilities	66.14M	261M	312M	309M	320M
Common Stock, Total	14.68M	14.68M	14.68M	14.68M	14.68M
Additional Paid In Capital	86.45M	86.45M	86.45M	86.45M	86.45M
Retained Earnings	23.52M	38.42M	68.82M	139M	133M
Comprehensive Income and Other	22.64M	57.32M	92.22M	87.24M	88.14M
Total Common Equity	147M	197M	262M	327M	322M
Minority Interest	5.36M	8.68M	10.98M	-	-
Total Equity	153M	206M	273M	327M	322M
Total Liabilities And Equity	219M	467M	585M	636M	642M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18.36M	18.36M	18.36M	18.36M	18.36M
ECS Total Common Shares Outstanding	18.36M	18.36M	18.36M	18.36M	18.36M
Book Value / Share	8.02	10.73	14.28	17.82	17.54
Tangible Book Value	146M	82.96M	149M	225M	205M
Tangible Book Value Per Share	7.98	4.52	8.14	12.28	11.18
Total Debt	41.25M	180M	213M	225M	219M
Net Debt	-59.7M	90.02M	137M	172M	196M
Minority Interest, Total (Incl. Fin. Div)	5.36M	8.68M	10.98M	-	-
Equity Method Investments, Total	-	-	-	63.31M	62.12M
Account Code - Inventory Valuation	5	-	5	5	5
Inventories - Raw Materials, Total	2.23M	1.94M	-	6.54M	6.86M
Inventories - Finished Goods, Total	-	-	7.8M	-	-
Land - (BS)	10M	10M	18.74M	21.21M	21.17M
Buildings, Total	3.11M	3.23M	8.6M	55.69M	56.87M
Machinery, Total	30.63M	66.36M	87.38M	182M	202M
Full Time Employees	460	864	1.05K	886	969
Accumulated Allowance for Doubtful Accounts (Supple)	165K	774K	458K	808K	863K
Order Backlog	-	221K	233M	224M	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	18M	14.9M	30.31M	69.88M	-6.1M
Depreciation & Amortization - CF	13.32M	24.23M	33.24M	41.99M	49.6M
Amortization of Goodwill and Intangible Assets - (CF)	205K	3.26M	3.59M	3.46M	3.5M
Depreciation & Amortization, Total	13.53M	27.49M	36.83M	45.45M	53.1M
Amortization of Deferred Charges, Total - (CF)	-	688K	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	1.13M	1.19M
Stock-Based Compensation (CF)	-	31.47M	30.84M	11.51M	3.19M
Other Operating Activities, Total	2.49M	7.25M	1.69M	-46.8M	8.42M
Change In Accounts Receivable	-6.43M	-16.39M	-38.07M	14.83M	-1.44M
Change In Inventories	-1.05M	289K	-5.86M	1.26M	-315K
Change in Unearned Revenues	2.64M	5.61M	11.81M	-11.5M	-3.49M
Change in Other Net Operating Assets	180K	16.17M	7.88M	-6.78M	9.51M
Cash from Operations	29.36M	87.47M	75.43M	78.98M	64.07M
Capital Expenditure	-15M	-27.53M	-101M	-73.78M	-18.71M
Cash Acquisitions	-	-134M	-	-	-22.03M
Investment in Marketable and Equity Securities, Total	-10.15M	-3.28M	11.42M	-311K	311K
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	12.83K	13.93K	9.38M	8.88M	3.56M
Cash from Investing	-25.14M	-164M	-79.79M	-65.21M	-36.87M
Short Term Debt Issued, Total	4.64K	-	-	-	-
Long-Term Debt Issued, Total	-	102M	37.84M	24.8M	10.3M
Total Debt Issued	4.64K	102M	37.84M	24.8M	10.3M
Short Term Debt Repaid, Total	-6.99K	-	-	-	-
Long-Term Debt Repaid, Total	-9.61M	-31.42M	-39.32M	-44.93M	-54.9M
Total Debt Repaid	-9.62M	-31.42M	-39.32M	-44.93M	-54.9M
Issuance of Common Stock	90.6M	237K	-	-	-
Repurchase of Common Stock	-2.99M	-	-	-	-
Other Financing Activities, Total	-2.87M	-3.8M	-4.2M	-10.84M	-12.74M
Cash from Financing	75.12M	66.82M	-5.67M	-30.97M	-57.34M
Foreign Exchange Rate Adjustments	-	583K	638K	-4.3M	5K
Miscellaneous Cash Flow Adjustments	-	-1	-	-	-1K
Net Change in Cash	79.34M	-9.46M	-9.39M	-21.5M	-30.14M
Supplemental Items
Cash Interest Paid	626K	3.8M	4.2M	10.84M	12.74M
Cash Income Tax Paid (Refund)	-	-	8.87M	1.51M	996K
Levered Free Cash Flow	2.68M	6.18M	-32.18M	-19.35M	41.84M
Unlevered Free Cash Flow	3.07M	8.55M	-29.56M	-12.05M	49.51M
Change In Net Working Capital	7.65M	8.55M	24.62M	5.7M	-12.23M
Net Debt Issued / Repaid	-9.62M	70.38M	-1.48M	-20.12M	-44.6M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.88	4.8	5.38	1.71	-0.05
Return on Total Capital	9.26	5.68	6.42	2.02	-0.06
Return On Equity %	20.19	10.17	13.62	23.28	-1.88
Return on Common Equity	19.09	8.66	13.21	23.72	-1.88
Margin Analysis
Gross Profit Margin %	85.2	81.1	83.55	79.78	78.54
SG&A Margin	60.03	62.48	61.19	58.47	59.46
EBITDA Margin %	16.53	12.17	14.48	10.76	8.31
EBITA Margin %	13.9	9.37	11.63	5.74	0.87
EBIT Margin %	13.76	8.34	10.77	4.76	-0.14
Income From Continuing Operations Margin %	14.04	5.77	7.84	19.86	-1.76
Net Income Margin %	12.68	4.72	7.29	19.86	-1.76
Net Avail. For Common Margin %	12.68	4.72	7.29	19.86	-1.76
Normalized Net Income Margin	6.94	3.17	5.49	11.94	-1.89
Levered Free Cash Flow Margin	1.89	1.96	-7.74	-5.5	12.1
Unlevered Free Cash Flow Margin	2.16	2.71	-7.11	-3.42	14.32
Asset Turnover
Asset Turnover	0.92	0.92	0.8	0.58	0.54
Fixed Assets Turnover	2.91	2.97	2.04	1.24	1.1
Receivables Turnover (Average Receivables)	5.6	7.05	5.61	4.59	4.66
Inventory Turnover (Average Inventory)	12.3	28.6	14.04	9.92	11.08
Short Term Liquidity
Current Ratio	4.35	1.87	1.66	1.61	0.61
Quick Ratio	4.18	1.73	1.55	1.47	0.54
Operating Cash Flow to Current Liabilities	0.89	0.91	0.61	0.84	0.31
Days Sales Outstanding (Average Receivables)	65.4	51.81	65.07	79.52	78.5
Days Outstanding Inventory (Average Inventory)	29.76	12.76	26	36.78	33.04
Average Days Payable Outstanding	177.88	128.35	150.03	140.9	134.02
Cash Conversion Cycle (Average Days)	-82.73	-63.78	-58.96	-24.6	-22.48
Long Term Solvency
Total Debt/Equity	27.02	87.47	77.96	68.71	67.89
Total Debt / Total Capital	21.27	46.66	43.81	40.73	40.44
LT Debt/Equity	18.66	70.54	62.78	54.38	23.56
Long-Term Debt / Total Capital	14.69	37.63	35.28	32.23	14.03
Total Liabilities / Total Assets	30.23	55.95	53.3	48.59	49.87
EBIT / Interest Expense	31.09	6.93	10.67	1.43	-0.04
EBITDA / Interest Expense	52.63	14.16	19.45	5.32	4.29
(EBITDA - Capex) / Interest Expense	28.74	6.92	-4.53	-0.99	2.76
Total Debt / EBITDA	1.25	3.34	2.61	3.61	4.15
Net Debt / EBITDA	-1.81	1.67	1.68	2.76	3.73
Total Debt / (EBITDA - Capex)	2.29	6.84	-11.22	-19.4	6.45
Net Debt / (EBITDA - Capex)	-3.31	3.42	-7.2	-14.83	5.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	164.78	122.46	31.71	-3.48	-1.73
Gross Profit, 1 Yr. Growth %	167.75	111.75	35.68	-5.33	-3.25
EBITDA, 1 Yr. Growth %	141.63	63.77	57.74	-31.61	-24.14
EBITA, 1 Yr. Growth %	162	49.99	64.82	-53.55	-85.11
EBIT, 1 Yr. Growth %	159.81	34.86	71.65	-58.05	-102.91
Earnings From Cont. Operations, 1 Yr. Growth %	158.39	-8.53	78.95	146.99	-108.73
Net Income, 1 Yr. Growth %	148.79	-17.22	103.43	130.55	-108.73
Normalized Net Income, 1 Yr. Growth %	144.57	1.53	131.91	113.85	-115.56
Diluted EPS Before Extra, 1 Yr. Growth %	-23.96	-22.37	103.7	169.07	-108.74
Accounts Receivable, 1 Yr. Growth %	8.24	151.29	31.25	-17.81	14.45
Inventory, 1 Yr. Growth %	88.23	-12.94	301.7	-16.16	4.82
Net Property, Plant and Equip., 1 Yr. Growth %	76.75	141.48	71.56	19.37	4.1
Total Assets, 1 Yr. Growth %	140.73	113.25	28.29	8.78	0.92
Tangible Book Value, 1 Yr. Growth %	262.69	-43.33	80	50.97	-8.94
Common Equity, 1 Yr. Growth %	257.25	33.65	33.17	24.75	-1.59
Cash From Operations, 1 Yr. Growth %	407.45	197.97	-11.68	4.71	-18.88
Capital Expenditures, 1 Yr. Growth %	823.5	83.46	295.09	-26.65	-74.64
Levered Free Cash Flow, 1 Yr. Growth %	299.09	26.6	-168.82	-45.04	-316.22
Unlevered Free Cash Flow, 1 Yr. Growth %	322.68	62.25	-160.15	-63.03	-510.9
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	36.18	142.7	71.17	5.57	-2.61
Gross Profit, 2 Yr. CAGR %	35.78	138.11	69.5	4.7	-4.29
EBITDA, 2 Yr. CAGR %	22.36	98.93	60.22	-0.41	-27.97
EBITA, 2 Yr. CAGR %	32.99	98.24	56.58	-17.01	-73.7
EBIT, 2 Yr. CAGR %	32.43	87.19	51.45	-19.87	-88.94
Earnings From Cont. Operations, 2 Yr. CAGR %	31.65	53.73	27.94	95.83	-53.57
Net Income, 2 Yr. CAGR %	30.95	43.51	29.77	116.57	-55.15
Normalized Net Income, 2 Yr. CAGR %	24.78	57.58	52.27	106.56	-42.32
Diluted EPS Before Extra, 2 Yr. CAGR %	25.49	-23.17	25.62	116.79	-51.54
Accounts Receivable, 2 Yr. CAGR %	25.63	64.92	81.61	3.86	-3.01
Inventory, 2 Yr. CAGR %	41.73	28.01	87.02	83.51	-6.26
Net Property, Plant and Equip., 2 Yr. CAGR %	89.82	106.6	103.54	43.11	11.48
Total Assets, 2 Yr. CAGR %	73.62	126.58	63.5	18.13	4.77
Tangible Book Value, 2 Yr. CAGR %	78.64	43.36	1	64.85	17.25
Common Equity, 2 Yr. CAGR %	78.48	118.51	33.41	28.89	10.8
Cash From Operations, 2 Yr. CAGR %	59.11	288.85	60.3	-3.84	-7.84
Capital Expenditures, 2 Yr. CAGR %	38.91	311.62	158.93	70.23	-56.87
Levered Free Cash Flow, 2 Yr. CAGR %	-16.7	203.35	156.82	-35.67	9.01
Unlevered Free Cash Flow, 2 Yr. CAGR %	-11.48	243.07	136.8	-50.48	23.25
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	36.1	60.38	97.96	35.34	3.08
Gross Profit, 3 Yr. CAGR %	35.94	57.46	97.41	32.41	1.98
EBITDA, 3 Yr. CAGR %	33	34.85	83.73	17.3	-9.04
EBITA, 3 Yr. CAGR %	43.06	38.43	85.89	0.81	-53.19
EBIT, 3 Yr. CAGR %	42.88	33.24	81.3	-4.98	-73.45
Earnings From Cont. Operations, 3 Yr. CAGR %	67.34	16.6	61.72	51.94	-30.57
Net Income, 3 Yr. CAGR %	66.11	12.38	61.21	57.17	-25.75
Normalized Net Income, 3 Yr. CAGR %	50.15	16.49	78.33	62.18	-12.77
Diluted EPS Before Extra, 3 Yr. CAGR %	54.21	6.92	6.26	53.84	-25.7
Accounts Receivable, 3 Yr. CAGR %	22.65	58.29	52.84	39.43	7.28
Inventory, 3 Yr. CAGR %	57.52	20.48	87.42	43.13	52.26
Net Property, Plant and Equip., 3 Yr. CAGR %	139.44	105.68	94.19	70.37	28.7
Total Assets, 3 Yr. CAGR %	65.87	85.94	86.01	42.74	12.09
Tangible Book Value, 3 Yr. CAGR %	60.68	21.84	54.66	15.48	35.26
Common Equity, 3 Yr. CAGR %	60.47	62.07	85.26	30.46	17.81
Cash From Operations, 3 Yr. CAGR %	40.7	96.12	135.37	39.08	-9.14
Capital Expenditures, 3 Yr. CAGR %	110.93	52.41	295.61	70.05	-9.76
Levered Free Cash Flow, 3 Yr. CAGR %	-	16.96	263.28	58.29	-3.64
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	29.71	243.91	31.72	0.25
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	49.17	35.68	45.18
Gross Profit, 5 Yr. CAGR %	-	-	48.49	33.75	43.16
EBITDA, 5 Yr. CAGR %	-	-	43.29	19.3	24.23
EBITA, 5 Yr. CAGR %	-	-	48.32	12.62	-16.76
EBIT, 5 Yr. CAGR %	-	-	46.25	8.51	-42.12
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	50.3	43.47	-4.58
Net Income, 5 Yr. CAGR %	-	-	50.49	46.1	-3.36
Normalized Net Income, 5 Yr. CAGR %	-	-	51	46.04	10.17
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	42.07	41.8	-24.73
Accounts Receivable, 5 Yr. CAGR %	-	-	43.5	33.74	27.42
Inventory, 5 Yr. CAGR %	-	-	68.71	42.57	42.06
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	124.38	77.9	55.53
Total Assets, 5 Yr. CAGR %	-	-	64.92	54.37	47.85
Tangible Book Value, 5 Yr. CAGR %	-	-	33.44	37.5	38.45
Common Equity, 5 Yr. CAGR %	-	-	49.05	47.88	50.83
Cash From Operations, 5 Yr. CAGR %	-	-	48.24	46.77	61.76
Capital Expenditures, 5 Yr. CAGR %	-	-	128.96	56.83	63.03
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	38.04	128.53
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	25.18	132.63